Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $24.34B | $19.99B | +21.73% |
Cost of Revenue | $9.75B | $5.34B | +82.54% |
Operating Income | $4.95B | $6.63B | -25.34% |
Net Income | $3.46B | $5.95B | -41.80% |
EPS (Basic) | $6.45 | $11.12 | -42.00% |
EPS (Diluted) | $6.40 | $11.06 | -42.13% |
SG&A Expense | $5.22B | $3.9B | +33.62% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $90.88B | $90.53B | +0.39% |
Current Assets | $26.77B | $48.48B | -44.79% |
Current Liabilities | $20.31B | $16.95B | +19.81% |
Stockholders' Equity | $7.53B | $7.66B | -1.68% |
Cash & Equivalents | $9.01B | $34.74B | -74.06% |
Long-Term Debt | $60.4B | $60.47B | -0.12% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $6.72B | $7.93B | -15.30% |
Investing Cash Flow | $-644M | $885M | -172.77% |
Financing Cash Flow | $-8.01B | $18.29B | -143.77% |
D&A | $4.2B | $2.69B | +55.89% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 20.3% | 33.1% | -12.81% |
Net Margin | 14.2% | — | — |
ROE | 46.0% | — | — |
ROA | 3.8% | — | — |
Current Ratio | $1.318 | — | — |
Other companies in Biotechnology